Ameriprise Financial Inc Amicus Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 386,948 shares of FOLD stock, worth $3.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
386,948
Previous 380,787 1.62%
Holding current value
$3.9 Million
Previous $3.78 Million 9.4%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$9.55 - $12.09 $58,837 - $74,486
6,161 Added 1.62%
386,948 $4.13 Million
Q2 2024

Aug 14, 2024
BUY
$9.04 - $11.75 $75,854 - $98,594
8,391 Added 2.25%
380,787 $3.78 Million
Q1 2024

May 15, 2024
SELL
$11.43 - $14.24 $1.79 Million - $2.24 Million
-156,978 Reduced 29.65%
372,396 $4.39 Million
Q4 2023

Feb 14, 2024
BUY
$9.97 - $14.52 $1.1 Million - $1.6 Million
110,120 Added 26.27%
529,374 $7.51 Million
Q3 2023

Nov 14, 2023
SELL
$11.78 - $13.86 $160,820 - $189,216
-13,652 Reduced 3.15%
419,254 $5.1 Million
Q2 2023

Aug 14, 2023
SELL
$10.72 - $13.3 $272,952 - $338,644
-25,462 Reduced 5.55%
432,906 $5.44 Million
Q1 2023

May 15, 2023
BUY
$10.91 - $13.54 $1.34 Million - $1.66 Million
122,904 Added 36.64%
458,368 $5.08 Million
Q4 2022

Feb 14, 2023
SELL
$9.89 - $12.7 $65,471 - $84,074
-6,620 Reduced 1.94%
335,464 $4.1 Million
Q3 2022

Nov 14, 2022
SELL
$9.82 - $12.75 $696,031 - $903,707
-70,879 Reduced 17.16%
342,084 $3.57 Million
Q2 2022

Aug 15, 2022
BUY
$6.23 - $11.12 $487,117 - $869,461
78,189 Added 23.36%
412,963 $4.43 Million
Q1 2022

May 16, 2022
BUY
$7.89 - $12.48 $191,466 - $302,852
24,267 Added 7.82%
334,774 $3.17 Million
Q4 2021

Feb 14, 2022
BUY
$9.82 - $12.44 $523,327 - $662,952
53,292 Added 20.72%
310,507 $3.59 Million
Q3 2021

Nov 15, 2021
BUY
$8.74 - $11.84 $456,551 - $618,486
52,237 Added 25.48%
257,215 $2.46 Million
Q2 2021

Aug 16, 2021
SELL
$8.71 - $10.72 $342,851 - $421,971
-39,363 Reduced 16.11%
204,978 $1.98 Million
Q1 2021

May 17, 2021
SELL
$9.2 - $23.86 $106,434 - $276,036
-11,569 Reduced 4.52%
244,341 $2.41 Million
Q4 2020

Feb 12, 2021
BUY
$13.47 - $24.89 $627,203 - $1.16 Million
46,563 Added 22.24%
255,910 $5.91 Million
Q3 2020

Nov 16, 2020
SELL
$12.89 - $15.89 $869,997 - $1.07 Million
-67,494 Reduced 24.38%
209,347 $2.96 Million
Q2 2020

Aug 14, 2020
SELL
$8.86 - $15.69 $811,310 - $1.44 Million
-91,570 Reduced 24.86%
276,841 $4.17 Million
Q1 2020

May 15, 2020
BUY
$6.63 - $11.16 $1.05 Million - $1.76 Million
157,726 Added 74.86%
368,411 $3.4 Million
Q4 2019

Feb 14, 2020
SELL
$7.48 - $10.75 $6.17 Million - $8.86 Million
-824,361 Reduced 79.64%
210,685 $2.05 Million
Q3 2019

Nov 14, 2019
BUY
$8.02 - $13.25 $363,057 - $599,814
45,269 Added 4.57%
1,035,046 $8.3 Million
Q2 2019

Aug 14, 2019
BUY
$10.96 - $14.4 $104,942 - $137,880
9,575 Added 0.98%
989,777 $12.4 Million
Q1 2019

May 15, 2019
BUY
$10.04 - $13.92 $89,868 - $124,597
8,951 Added 0.92%
980,202 $13.3 Million
Q4 2018

Feb 14, 2019
SELL
$8.38 - $13.44 $13.7 Million - $22 Million
-1,636,497 Reduced 62.76%
971,251 $9.31 Million
Q3 2018

Nov 14, 2018
BUY
$11.6 - $16.54 $95,514 - $136,190
8,234 Added 0.32%
2,607,748 $31.5 Million
Q2 2018

Aug 14, 2018
BUY
$13.13 - $17.09 $6.89 Million - $8.97 Million
524,979 Added 25.31%
2,599,514 $40.6 Million
Q1 2018

May 15, 2018
BUY
$13.76 - $17.12 $28.5 Million - $35.5 Million
2,074,535 New
2,074,535 $31.2 Million

Others Institutions Holding FOLD

# of Institutions
312
Shares Held
314M
Call Options Held
630K
Put Options Held
669K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.83B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email